Earnings Feed
Start Free
OSIRIS THERAPEUTICS, INC.·4

Oct 2, 6:40 AM ET

OSIRIS THERAPEUTICS, INC. 4

4 · OSIRIS THERAPEUTICS, INC. · Filed Oct 2, 2014

Insider Transaction Report

Form 4
Period: 2014-09-30
OSIRIS THERAPEUTICS, INC.OSIR
Neumayer Matthew Paul
Principal Accounting Officer
Transactions
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2014-09-30$7.73/sh−2,625$20,291→ 0 total
    Exercise: $7.73From: 2015-02-12Exp: 2014-09-30→ Common Stock (2,625 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2014-09-30$5.08/sh−1,750$8,890→ 2,625 total
    Exercise: $5.08From: 2015-03-23Exp: 2014-09-30→ Common Stock (1,750 underlying)
  • Disposition to Issuer

    Incentive Stock Option (right to buy)

    2014-09-30$7.13/sh−1,000$7,130→ 4,375 total
    Exercise: $7.13From: 2015-02-14Exp: 2014-09-30→ Common Stock (1,000 underlying)
Footnotes (1)
  • [F1]Unvested stock options that were forfeited concurrent with the Reporting Person's termination from employment with the Registrant, consistent with the provisions of the Amended and Restated 2006 Omnibus Plan.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -